## Clinical Diagnosis **Key Point:** Acute bacterial meningitis with CSF showing pleocytosis (450 WBC/μL with neutrophil predominance), elevated protein, hypoglycorrhachia (CSF glucose 25 mg/dL with normal serum glucose), and Gram-positive diplococci is diagnostic of *Streptococcus pneumoniae* meningitis. ## Pathophysiology & Treatment Rationale **High-Yield:** Meningitis requires: 1. **High-dose, bactericidal agents** with excellent CNS penetration 2. **Combination therapy** to cover penicillin-resistant *S. pneumoniae* (PRSP) 3. **Adjunctive rifampicin** to enhance CNS penetration and sterilization 4. **Vancomycin** for PRSP coverage (cephalosporins alone may fail in PRSP meningitis) **Clinical Pearl:** The blood-brain barrier (BBB) limits antibiotic penetration. Only agents with high lipid solubility and small molecular weight cross the BBB effectively. In meningitis, CSF penetration is the critical pharmacokinetic parameter, not serum levels. ## Antibiotic Regimen for Pneumococcal Meningitis | Agent | Dose (Meningitis) | CNS Penetration | PRSP Coverage | Rationale | |-------|-------------------|-----------------|---------------|----------| | **Ceftriaxone** | 2 g IV 4-hourly | Excellent (20–30% of serum) | Good | Beta-lactam backbone | | **Vancomycin** | 15–20 mg/kg IV 8–12-hourly | Moderate (15–20% of serum) | Excellent | For PRSP; synergy with cephalosporin | | **Rifampicin** | 600 mg IV 12-hourly | Excellent (100% of serum) | Excellent | Adjunctive; enhances CSF penetration | **Warning:** Do NOT use penicillin G alone — PRSP meningitis has high mortality with penicillin monotherapy. Chloramphenicol is outdated and inferior. Cephalosporin monotherapy (without vancomycin) is inadequate for PRSP meningitis. **Mnemonic:** **VCR** = **V**ancomycin + **C**ephalosporin (Ceftriaxone/Cefotaxime) + **R**ifampicin for meningitis. ## Dosing in Meningitis - **Ceftriaxone:** 2 g IV 4-hourly (total 12 g/day) — higher than pneumonia - **Vancomycin:** 15–20 mg/kg IV 8–12-hourly — target CSF levels 15–20 μg/mL - **Rifampicin:** 600 mg IV 12-hourly — synergistic with vancomycin **Duration:** 10–14 days for pneumococcal meningitis ## Adjunctive Therapy - **Dexamethasone:** 10 mg IV 6-hourly for 4 days (reduces neurological sequelae and mortality) - Given 15–20 minutes before or with first antibiotic dose - Reduces inflammation and improves antibiotic CNS penetration
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.